Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs
A Pathophysiologic Study of Development of Distal Symmetrical Polyneuropathy in Individuals With Advanced HIV-1 Infection and Prior Antiretroviral Exposure
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Listed as NCT00017771, this observational or N/A phase trial focuses on HIV Infections and Peripheral Nervous System Disease and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 11 times since 2001, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jun 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Baltimore, United States, Birmingham, United States, Chicago, United States, Dallas, United States, Denver, United States, Honolulu, United States, Indianapolis, United States, Los Angeles, United States, New York, United States, Philadelphia, United States and 4 more location s